Literature DB >> 9083888

Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts.

C M Kokron1, F A Bonilla, H C Oettgen, N Ramesh, R S Geha, F Pandolfi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9083888     DOI： 10.1023/a:1027322314256

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  236 in total

1.  Profound block in thymocyte development in mice lacking p56lck.

Authors:  T J Molina; K Kishihara; D P Siderovski; W van Ewijk; A Narendran; E Timms; A Wakeham; C J Paige; K U Hartmann; A Veillette
Journal:  Nature       Date:  1992-05-14       Impact factor: 49.962

2.  Two genetically separable steps in the differentiation of thymic epithelium.

Authors:  M Nehls; B Kyewski; M Messerle; R Waldschütz; K Schüddekopf; A J Smith; T Boehm
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

3.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

Authors:  L Soong; J C Xu; I S Grewal; P Kima; J Sun; B J Longley; N H Ruddle; D McMahon-Pratt; R A Flavell
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Peripheral lymphoid development and function in TCR mutant mice.

Authors:  P Mombaerts; E Mizoguchi; H G Ljunggren; J Iacomini; H Ishikawa; L Wang; M J Grusby; L H Glimcher; H J Winn; A K Bhan
Journal:  Int Immunol       Date:  1994-07       Impact factor: 4.823

5.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Authors:  W L Hazenbos; J E Gessner; F M Hofhuis; H Kuipers; D Meyer; I A Heijnen; R E Schmidt; M Sandor; P J Capel; M Daëron; J G van de Winkel; J S Verbeek
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

6.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Immune responses in interleukin-2-deficient mice.

Authors:  T M Kündig; H Schorle; M F Bachmann; H Hengartner; R M Zinkernagel; I Horak
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Constitutive activation of Src family kinases in mouse embryos that lack Csk.

Authors:  S Nada; T Yagi; H Takeda; T Tokunaga; H Nakagawa; Y Ikawa; M Okada; S Aizawa
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582
View more
  4 in total

1.  Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness.

Authors:  M V Ursini; L Gaetaniello; R Ambrosio; E Matrecano; A J Apicella; M C Salerno; C Pignata
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

3.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.

Authors:  C L Halbert; T A Standaert; C B Wilson; A D Miller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.

Authors:  Jamal Alzubi; Celeste Pallant; Claudio Mussolino; Steven J Howe; Adrian J Thrasher; Toni Cathomen
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.